2024 ICD-10-CM Diagnosis Code T38.0X5A

Adverse effect of glucocorticoids and synthetic analogues, initial encounter

ICD-10-CM Code:
T38.0X5A
ICD-10 Code for:
Adverse effect of glucocort/synth analog, init
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Not chronic
Code Navigator:

Code Classification

  • Injury, poisoning and certain other consequences of external causes
    (S00–T88)
    • Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
      (T36-T50)
      • Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified
        (T38)

T38.0X5A is a billable diagnosis code used to specify a medical diagnosis of adverse effect of glucocorticoids and synthetic analogues, initial encounter. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

This code describes a circumstance which influences the patient's health status but not a current illness or injury. The code is unacceptable as a principal diagnosis.

T38.0X5A is an initial encounter code, includes a 7th character and should be used while the patient is receiving active treatment for a condition like adverse effect of glucocorticoids and synthetic analogues. According to ICD-10-CM Guidelines an "initial encounter" doesn't necessarily means "initial visit". The 7th character should be used when the patient is undergoing active treatment regardless if new or different providers saw the patient over the course of a treatment. The appropriate 7th character codes should also be used even if the patient delayed seeking treatment for a condition.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Acne of external chemical origin
  • ACTH deficiency
  • Adverse reaction following injection of substance
  • Atrophy of skin due to drug
  • Atrophy of skin due to drug
  • Atrophy of skin due to drug
  • Atrophy of skin due to systemic corticosteroid
  • Cataract of left eye caused by corticosteroid
  • Cataract of posterior subcapsule of left eye
  • Cataract of posterior subcapsule of right eye
  • Cataract of right eye caused by corticosteroid
  • Corticosteroid induced cataract
  • Corticosteroid induced cataract
  • Corticosteroid induced cataract
  • Corticosteroid-induced neutrophilia
  • Corticosteroid-induced open angle glaucoma
  • Corticosteroid-induced open angle glaucoma
  • Corticosteroid-induced open angle glaucoma
  • Corticosteroid-induced telangiectasia
  • Corticosteroids adverse reaction
  • Cortisone adverse reaction
  • Cushingoid facies
  • Cutaneous atrophy due to corticosteroids
  • Desoxymethasone adverse reaction
  • Dexamethasone adverse reaction
  • Diabetes mellitus caused by chemical
  • Diabetes mellitus caused by chemical
  • Drug-induced cataract
  • Drug-induced cataract
  • Drug-induced cataract
  • Drug-induced diabetes mellitus
  • Drug-induced diabetes mellitus
  • Drug-induced glaucoma
  • Drug-induced glaucoma
  • Drug-induced glaucoma
  • Drug-induced glaucoma
  • Drug-induced hyperglycemia
  • Drug-induced immunodeficiency
  • Drug-induced neutrophilia
  • Drug-induced osteoporosis
  • Drug-induced panniculitis
  • Drug-induced telangiectasia
  • Glaucoma of left eye caused by drug
  • Glaucoma of right eye caused by drug
  • Glaucoma suspect caused by corticosteroid
  • Glaucoma suspect caused by corticosteroid
  • Glaucoma suspect caused by corticosteroid
  • Glaucoma suspect caused by corticosteroid
  • Glaucoma suspect of bilateral eyes caused by corticosteroid
  • Glaucoma suspect of left eye caused by corticosteroid
  • Glaucoma suspect of left eye caused by corticosteroid
  • Glaucoma suspect of right eye caused by corticosteroid
  • Glaucoma suspect of right eye caused by corticosteroid
  • Hyperlipidemia caused by steroid
  • Immunodeficiency secondary to corticosteroid
  • Intra-articular steroid-induced arthritis and periarthritis
  • Lipoatrophy due to injected corticosteroid
  • Lipoatrophy due to injected drug
  • Localized lipoatrophy
  • Methylprednisolone adverse reaction
  • Neutrophilia disorder
  • Open angle glaucoma of left eye caused by corticosteroid
  • Open angle glaucoma of right eye caused by corticosteroid
  • Osteonecrosis caused by glucocorticoid
  • Osteoporosis due to corticosteroid
  • Panniculitis caused by corticosteroid therapy
  • Perioral dermatitis due to corticosteroid
  • Prednisolone adverse reaction
  • Prednisone adverse reaction
  • Rectal prednisolone preparations adverse reaction
  • Rosacea
  • Rosacea due to topical corticosteroid
  • Secondary hyperlipidemia
  • Secondary myopathy
  • Skin disease attributable to corticosteroid therapy
  • Skin disease attributable to corticosteroid therapy
  • Skin disease attributable to corticosteroid therapy
  • Skin disease attributable to corticosteroid therapy
  • Skin disease attributable to corticosteroid therapy
  • Skin disease attributable to corticosteroid therapy
  • Stellate pseudoscar
  • Stellate pseudoscar due to corticosteroid
  • Steroid acne
  • Steroid suppression of ACTH secretion
  • Steroid withdrawal syndrome
  • Steroidal ecchymosis
  • Steroid-induced diabetes
  • Steroid-induced diabetes mellitus without complication
  • Steroid-induced glaucoma glaucomatous stage
  • Steroid-induced hyperglycemia
  • Steroid-induced myopathy
  • Steroid-induced osteopenia
  • Steroid-modified tinea infection
  • Steroid-modified tinea infection
  • Steroid-modified tinea infection of foot
  • Steroid-modified tinea infection of lower limb
  • Steroid-modified tinea infection of lower limb
  • Tinea pedis

Clinical Classification

Clinical Information

  • Rosacea

    a cutaneous disorder primarily of convexities of the central part of the face, such as forehead; cheek; nose; and chin. it is characterized by flushing; erythema; edema; rhinophyma; papules; and ocular symptoms. it may occur at any age but typically after age 30. there are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular (national rosacea society's expert committee on the classification and staging of rosacea, j am acad dermatol 2002; 46:584-7).
  • Rosaceae

    the rose plant family in the order rosales and class magnoliopsida. they are generally woody plants. a number of the species of this family contain cyanogenic compounds.
  • Tinea Pedis

    dermatological pruritic lesion in the feet, caused by trichophyton rubrum, t. mentagrophytes, or epidermophyton floccosum.
  • Rosales

    an order of the class magnoliopsida. its members include some of the most known ornamental and edible plants of temperate zones including roses, apples, cherries, and peaches.

Coding Guidelines

When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified (T38). Use the following options for the aplicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Code Edits

The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10-CM Code Edits are applicable to this code:

  • Unacceptable principal diagnosis - There are selected codes that describe a circumstance which influences an individual's health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.

Convert T38.0X5A to ICD-9-CM

  • ICD-9-CM Code: 995.29 - Adv eff med/biol NEC/NOS
    Combination Flag - Multiple codes are needed to describe the source diagnosis code. Correct coding should be done based on contextual judgment.
  • ICD-9-CM Code: E932.0 - Adv eff corticosteroids
    Combination Flag - Multiple codes are needed to describe the source diagnosis code. Correct coding should be done based on contextual judgment.

Table of Drugs and Chemicals

The parent code T38.0X5 of the current diagnosis code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.

According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.

Substance Poisoning
Accidental
(unintentional)
Poisoning
Accidental
(self-harm)
Poisoning
Assault
Poisoning
Undetermined
Adverse
effect
Underdosing
Adrenal (extract, cortex or medulla) (glucocorticoids) (hormones) (mineralocorticoids)T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Adrenal (extract, cortex or medulla) (glucocorticoids) (hormones) (mineralocorticoids)
  »ENT agent
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Adrenal (extract, cortex or medulla) (glucocorticoids) (hormones) (mineralocorticoids)
  »ophthalmic preparation
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Adrenal (extract, cortex or medulla) (glucocorticoids) (hormones) (mineralocorticoids)
  »topical NEC
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
AristocortT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Aristocort
  »ENT agent
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Aristocort
  »ophthalmic preparation
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Aristocort
  »topical NEC
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
CelestoneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Celestone
  »topical
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
ClocortoloneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
CloprednolT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
CortateT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cort-DomeT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cort-Dome
  »ENT agent
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cort-Dome
  »ophthalmic preparation
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cort-Dome
  »topical NEC
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
CortefT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortef
  »ENT agent
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortef
  »ophthalmic preparation
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortef
  »topical NEC
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
CorticosteroidT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Corticosteroid
  »ENT agent
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Corticosteroid
  »mineral
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Corticosteroid
  »ophthalmic
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Corticosteroid
  »topical NEC
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortisone (acetate)T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortisone (acetate)
  »ENT agent
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortisone (acetate)
  »ophthalmic preparation
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortisone (acetate)
  »topical NEC
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
CortivazolT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
CortogenT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortogen
  »ENT agent
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortogen
  »ophthalmic preparation
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
CortoneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortone
  »ENT agent
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortone
  »ophthalmic preparation
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
CortrilT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortril
  »ENT agent
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortril
  »ophthalmic preparation
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Cortril
  »topical NEC
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
DecadronT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Decadron
  »ENT agent
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Decadron
  »ophthalmic preparation
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Decadron
  »topical NEC
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
DeflazacortT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
DeltasoneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
DeltraT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
DexamethasoneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Dexamethasone
  »ENT agent
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Dexamethasone
  »ophthalmic preparation
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Dexamethasone
  »topical NEC
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
DOCAT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
FlorinefT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Florinef
  »ENT agent
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Florinef
  »ophthalmic preparation
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Florinef
  »topical NEC
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
FluohydrocortisoneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Fluohydrocortisone
  »ENT agent
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Fluohydrocortisone
  »ophthalmic preparation
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Fluohydrocortisone
  »topical NEC
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Fluorinated corticosteroidsT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
FluprednisoloneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Fluticasone propionateT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
GlucocorticoidsT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
GlucocorticosteroidT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
HydeltraT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Hydrocortisone (derivatives)T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Hydrocortisone (derivatives)
  »aceponate
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Hydrocortisone (derivatives)
  »ENT agent
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Hydrocortisone (derivatives)
  »ophthalmic preparation
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Hydrocortisone (derivatives)
  »topical NEC
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
HydrocortoneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Hydrocortone
  »ENT agent
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Hydrocortone
  »ophthalmic preparation
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Hydrocortone
  »topical NEC
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
KenacortT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
MeprednisoneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
ParamethasoneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Paramethasone
  »acetate
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
PercortenT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
PrednisoloneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Prednisolone
  »ENT agent
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Prednisolone
  »ophthalmic preparation
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Prednisolone
  »steaglate
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Prednisolone
  »topical NEC
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
PrednisoneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
PrednylideneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
SteroidT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Steroid
  »anabolic
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Steroid
  »androgenic
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Steroid
  »antineoplastic, hormone
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Steroid
  »antineoplastic, hormone
    »estrogen
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Steroid
  »ENT agent
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Steroid
  »ophthalmic preparation
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Steroid
  »topical NEC
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
TriamcinoloneT38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Triamcinolone
  »ENT agent
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Triamcinolone
  »hexacetonide
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Triamcinolone
  »ophthalmic preparation
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6
Triamcinolone
  »topical NEC
T38.0X1T38.0X2T38.0X3T38.0X4T38.0X5T38.0X6

Patient Education


Drug Reactions

Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions, such as drug interactions, side effects, and allergies.

What is a drug interaction?

A drug interaction is a change in the way a drug acts in the body when taken with certain other drugs, foods, or supplements or when taken while you have certain medical conditions. Examples include:

  • Two drugs, such as aspirin and blood thinners
  • Drugs and food, such as statins and grapefruit
  • Drugs and supplements, such as gingko and blood thinners
  • Drugs and medical conditions, such as aspirin and peptic ulcers

Interactions could cause a drug to be more or less effective, cause side effects, or change the way one or both drugs work.

What are side effects?

Side effects are unwanted, usually unpleasant, effects caused by medicines. Most are mild, such as a stomachache, dry mouth, or drowsiness, and go away after you stop taking the medicine. Others can be more serious. Sometimes a drug can interact with a disease that you have and cause a side effect. For example, if you have a heart condition, certain decongestants can cause you to have a rapid heartbeat.

What are drug allergies?

Drug allergies are another type of reaction. They can range from mild to life-threatening. Skin reactions, such as hives and rashes, are the most common type. Anaphylaxis, a serious allergic reaction, is less common.

How can I stay safe when taking medicines?

When you start a new prescription or over-the-counter medicine, make sure you understand how to take it correctly. Know which other medicines, foods, and supplements you need to avoid. Always talk to your health care provider or pharmacist if you have questions about your medicines.


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.